Alexandria Real Estate Equities was among the participants as the drug discovery technology provider closed its series C round.
US-based drug discovery platform provider Alloy Therapeutics has completed a $75m series C round that included Alexandria Venture Investments, the venture capital arm of life sciences real estate investment trust Alexandria Real Estate Equities.
VC firms 8VC and Presight Capital co-led the round with entrepreneur Peter Thiel, and it also featured Founders Fund, Gaingels, Mubadala Capital, Luma Bio-IT, Ulysses Diversified Holdings and an unnamed sovereign wealth fund.
Founded in 2017, Alloy provides drug discovery technology and services for academic scientists,…
